← Back to Search

Behavioural Intervention

ENTRUST for AIDS

N/A
Recruiting
Led By Elena Cyrus, PhD
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male at birth
Identify as a woman/transgender woman
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial aims to test the idea that helping transgender women with financial stability and counseling will make it more likely for them to use substance abuse and HIV prevention services. Additionally, it will see if transgender women

Who is the study for?
This trial is for transgender women, particularly those who are financially unstable and may need help with substance use or HIV prevention/treatment. It's open to individuals seeking support in these areas but not to those who don't meet the specific inclusion criteria set by the researchers.Check my eligibility
What is being tested?
The ENTRUST trial is testing whether financial stability and tailored counseling can help transgender women better access services for substance use, PrEP (HIV prevention), or adhere to their ART (HIV treatment) if they are living with HIV.See study design
What are the potential side effects?
Since this trial focuses on economic navigation and counselling rather than medical interventions, traditional side effects like you'd see with medications aren't a concern here.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was assigned male at birth.
Select...
I identify as a woman or transgender woman.
Select...
I do not regularly take PrEP, less than four times a week.
Select...
I am 18 years old or older.
Select...
I have no allergies to PrEP or tenofovir.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with substance abuse
Secondary outcome measures
Rate of substance use in transgender women

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ENTRUSTExperimental Treatment2 Interventions
The proposed intervention 'ENTRUST' will address structural disparities transgender women encounter by providing skills to aid with economic navigation while simultaneously strengthening and improving social cohesion to increase the odds of them linking to care that is available to them.
Group II: ControlActive Control2 Interventions
Comparison control group.

Find a Location

Who is running the clinical trial?

National Institute of Drug AbuseFED
9 Previous Clinical Trials
14,409 Total Patients Enrolled
Survivor's PathwayUNKNOWN
University of Central FloridaLead Sponsor
79 Previous Clinical Trials
1,098,250 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for patients to participate in this clinical trial?

"According to the information provided on clinicaltrials.gov, this particular trial is not currently accepting participants. It was initially posted on January 1st, 2024 and last updated on January 8th, 2024. However, there are presently a total of 107 other ongoing clinical trials actively seeking eligible candidates for participation."

Answered by AI
~73 spots leftby Nov 2025